Rombotis Spiro George 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jan 29, 2013
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Common Stock, $0.001 par value per share
2013-01-25+10,791→ 168,292 total - Award
Common Stock, $0.001 par value per share
2013-01-25+20,000→ 157,501 total
Footnotes (3)
- [F1]These securities were issued as part of the Issuer's annual equity compensation to executive officers under the Issuer's Amended and Restated 2006 Equity Incentive Plan.
- [F2]Of the shares of common stock reported, 142 shares are held indirectly by Mr. Rombotis through his IRA account and 30,714 shares are represented by unvested restricted stock units.
- [F3]Of the shares of common stock reported, 20,000 are represented by restricted stock units which will vest upon the fulfillment of certain clinical and financial conditions and terminate if they have not vested by December 31, 2014.